CDISC Legacy Data ConversionCDISC data standardization facilitates clinical data pooling, standard reporting, and data transfers with partners. Additional important reasons for converting legacy (or on-ongoing) clinical study data into a CDISC format are : - To comply with the Food and Drug administration (FDA) submission requirements - To prepare clinical data into a data warehouse ready format to maximize its usability CDISC legacy data conversion process
The FDA has embraced the CDISC SDTM and CRT-DDS as the standard data model for submitting tabulation data in an electronic format. FDA reviewers are requesting sponsors to use the SDTM model to vastly improve their review efficiency and accuracy. The Business & Decision Life Sciences data conversion process uses established techniques for converting clinical study data to the CDISC SDTM and metadata (define.xml) format for regulatory submission. The analysis datasets can also be prepared into ADaM format. Data warehouse preparationSponsors are realizing the added value of a global data standard across all systems and processes. Study data and metadata are typically supplied by third party providers, and the data may currently exist in different, non-compatible formats. To maximize the usability and value of existing data, Business & Decision Life Sciences helps sponsors to convert all existing data into a data warehouse-ready, CDISC standard structure. Benefits
|
||
© 2008, 2009, 2010
All rights reserved
Accessibility | legal notice | Contact | sitemap |